Join me in Boston on Thursday to meet biotech’s top startups

We’re putting the finishing touches to this year’s Endpoints 11, our annual special report looking at some of the top up-and-coming private biotechs in the industry. And we’ll be rolling the report out on Thursday morning at 7 am.

Bioregnum Opinion Column by John Carroll

That evening, in Boston’s Seaport enclave, we’ll be celebrating the companies and the executives who founded them in a special event at The 105, in the lobby of CRISPR Therapeutics’ new headquarters building. This will start with some one-on-one networking at 6 pm and will follow up at 7 pm with a fireside chat with MIT’s Phil Sharp, the Nobel Prize-winning scientist who co-founded Alnylam and Biogen.

Then we’ll hand out the awards.

This return to live events — we’ll be streaming this as well — will continue in London next month, with #EUBIO22, our annual set of events focused on the European scene, which will be held at Silicon Valley Bank’s London HQ. And we’ll be in San Francisco in January for two days of events during JP Morgan.

Here’s the link to the Endpoints 11, where you can get tickets. If you can make it, drop me a line and come by and say hello. It’s going to be an interesting crowd. And that’s a promise.

therapeutics
crispr
biotech